Related Experiment Video
Updated: Aug 8, 2026

Anterior High-Resolution Optical Coherence Tomography in the Diagnosis and Therapeutic Monitoring of Ocular Surface Squamous Neoplasia
Published on: August 9, 2024
Bilateral Ophthalmoplegia After Neoadjuvant Pembrolizumab for Oral Cavity Squamous Cell Carcinoma
Leonard E Estephan1, Peter Jacoby2, David M Cognetti1
1Department of Otolaryngology-Head and Neck Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
Abstract:
The role of immune checkpoint inhibition (ICI) therapy in the treatment of head and neck squamous cell carcinoma (HNSCC) is expanding with increased utilization of neoadjuvant and adjuvant pembrolizumab in the setting of locally advanced disease. This report describes the presentation and management of the first known case of pembrolizumab-induced isolated bilateral ophthalmoplegia in a patient with locally advanced oral cavity squamous cell carcinoma. Multidisciplinary teams, including head and neck surgeons, are integral to the management of treatment-related complications following ICI therapy, and comprehensive guidelines are necessary optimize outcomes for patients with HNSCC.
Related Concept Videos
Angle Closure Glaucoma: Treatment
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Glaucoma: Overview